Parallax Volatility Advisers’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1132 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1161 |
|
|
2023
Q3 | – | Sell |
-10,085
| Closed | -$255K | – | 1196 |
|
|
2023
Q2 | $255K | Sell |
10,085
-14,662
| -59% | -$371K | ﹤0.01% | 458 |
|
|
2023
Q1 | $797K | Buy |
+24,747
| New | +$797K | ﹤0.01% | 337 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1473 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1573 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1595 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2608 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2659 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2555 |
|
|
2018
Q2 | – | Sell |
-4,040
| Closed | -$124K | – | 2484 |
|
|
2018
Q1 | $124K | Sell |
4,040
-30,754
| -88% | -$944K | ﹤0.01% | 440 |
|
|
2017
Q4 | $1.24M | Buy |
+34,794
| New | +$1.24M | ﹤0.01% | 297 |
|